Loading...

The Scientist

» grant, immunology, disease/medicine and culture

Most Recent

image: The Benefits of Trepidation

The Benefits of Trepidation

By Abigail Marsh | November 1, 2017

While wiping fear from our brains may seem attractive, the emotion is an essential part of our behavioral repertoire.

1 Comment

image: The Wada Test, 1948

The Wada Test, 1948

By Philip Jaekl | November 1, 2017

A decades-old neurological procedure developed under unique and difficult conditions in postwar Japan remains critical to the treatment of epilepsy.

0 Comments

image: 2017 Life Science Salary Survey

2017 Life Science Salary Survey

By Aggie Mika | November 1, 2017

Industry professionals make more than academic researchers, but for professors, it may not be about the money.

0 Comments

image: Getting Drugs Past the Blood-Brain Barrier

Getting Drugs Past the Blood-Brain Barrier

By Amanda B. Keener | November 1, 2017

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.

3 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: Genetic Risk Factors for Breast Cancer Identified

Genetic Risk Factors for Breast Cancer Identified

By Ashley P. Taylor | October 23, 2017

Researchers identify 72 novel genetic variants associated with breast cancer risk.

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

image: Compound Found in Red Wine Boosts Immune Cell Function

Compound Found in Red Wine Boosts Immune Cell Function

By Catherine Offord | October 17, 2017

At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 

1 Comment

image: Cancers Relapse by Feeding Off Immune Signals

Cancers Relapse by Feeding Off Immune Signals

By Shawna Williams | October 16, 2017

In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.

0 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. The Second March for Science a Smaller Affair
  4. RNA Injection Restores Hearing in Guinea Pigs